[THERAPEUTIC TRIAL OF THE EFFECT OF A MONOAMINE OXIDASE INHIBITOR ON APATHY OF MENTALLY DEFECTIVE CHILDREN].
D000223:Adaptation, Psychological; D000293:Adolescent; D057565:Apathy; D035843:Biomedical Research; D001921:Brain; D001925:Brain Damage, Chronic; D001930:Brain Injuries; D002648:Child; D004314:Down Syndrome; D004358:Drug Therapy; D004495:Education of Persons with Intellectual Disabilities; D006801:Humans; D008607:Intellectual Disability; D008996:Monoamine Oxidase Inhibitors; D009526:Nialamide; D019989:Persons with Intellectual Disabilities; D010919:Placebos
D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D009526:Nialamide
ADAPTATION, PSYCHOLOGICAL; ADOLESCENCE; BRAIN DAMAGE, CHRONIC; CHILD; CLINICAL RESEARCH; DRUG THERAPY; EDUCATION OF MENTALLY RETARDED; MENTAL RETARDATION; MONGOLISM; NIALAMIDE; PLACEBOS
ESSAI TH'ERAPEUTIQUE D'UN INHIBITEUR DE LA MONOAMINOXYDASE SUR L'APATHIE DES ENFANTS D'EBILES MENTAUX.